![Marie-Noëlle Ip](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Marie-Noëlle Ip worked as a Program Director at the Council of Canadian Academies, an Operations Director at Verlyx Pharma, Inc., and a Principal at BCE, Inc. from 1989 to 2003.
Eerdere bekende functies van Marie-Noëlle Ip
Bedrijven | Functie | Einde |
---|---|---|
BCE INC. | Corporate Officer/Principal | 01-01-2003 |
Council of Canadian Academies | Corporate Officer/Principal | - |
Verlyx Pharma, Inc.
![]() Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Operationeel Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BCE INC. | Communications |
Bedrijven in privébezit | 2 |
---|---|
Verlyx Pharma, Inc.
![]() Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
Council of Canadian Academies |